Seeking Alpha

Biopharmaceutical company Cell Therapeutics (CTIC +6.9%) gains on optimism ahead of its...

Biopharmaceutical company Cell Therapeutics (CTIC +6.9%) gains on optimism ahead of its presentation tomorrow at the annual Rodman & Renshaw global investment conference. The company is slated to discuss the marketing plans for its non-Hodgkin's lymphoma treatment Pixuvri in the European Union, as well as update the status of clinical trials of pacritinib, including plans to initiate a phase III trial in Q4.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs